S. Mantha et al., RELATIVE EFFECTIVENESS OF 4 PREOPERATIVE TESTS FOR PREDICTING ADVERSECARDIAC OUTCOMES AFTER VASCULAR-SURGERY - A METAANALYSIS, Anesthesia and analgesia, 79(3), 1994, pp. 422-433
Various noninvasive tests have been proposed to stratify perioperative
cardiovascular risk, including dipyridamole thallium scintigraphy (DT
S), ejection fraction estimation by radionuclide ventriculography (RNV
), ischemia monitoring by ambulatory electrocardiography (AECG), and d
obutamine stress echocardiography (DSE). Which of these tests is most
effective for predicting adverse perioperative cardiac outcome? To ans
wer this question, and also to stimulate future studies, we evaluated
56 studies examining one or more of the four tests. We conducted meta-
analysis on 20 studies that met the inclusion criteria. Outcome measur
es evaluated were cardiac death or myocardial infarction occurring dur
ing hospital stay or within 1 mo after surgery. Relative risk (RR), wh
ich is the probability of adverse cardiac outcome when the test is pos
itive divided by the probability of adverse outcome when the test is n
egative, was used to combine evidence from different studies. An empir
ical Bayes procedure with a normal-normal hierarchic model was then us
ed to obtain a meta-analytic confidence interval for the overall media
n of the relative risks. The between-study variance was estimated usin
g the method of moments approach described by DerSimonian and Laird (C
ontrolled Clin Trials 1986;7:177-88). Combined (median) RR [95% confid
ence interval (CI)] and the number of studies included in our meta-ana
lysis for different evaluative tests were as follows: DTS 4.6 (2.1-10.
4) (n = 6); RNV 3.7 (1.6-8.3) (n = 5); AECG 2.7 (1.4-5.1) (n = 6), and
DSE 6.2 (1.7-22.8) (n = 3). We conclude that while DTS, RNV,AECG, and
DSE are effective (the 95% CIs are greater than 1.0) in predicting th
e cardiac outcome after vascular surgery, the data are not definitive
in determining the optimal test (95% CIs for RR overlap). Future studi
es should include DSE, as this test. shows great promise for predictin
g adverse cardiac events after vascular surgery.